Illumina Names Chief Commercial Officer and Chief Legal Officer

Illumina Inc. has welcomed two new members to its C-Suite, appointing Mike Sullivan as chief commercial officer and Julie Coletti as chief legal officer.

The appointments add experienced leaders to Illumina’s executive leadership team as the company continues advancing its strategy, serving customers, and driving growth.

“We are excited to welcome Mike and Julie to Illumina,” Illumina CEO Jacob Thaysen stated. “Mike brings deep commercial expertise, a customer-first mindset, and significant experience scaling global organizations, while Julie is a highly accomplished legal and business leader with deep experience across the life sciences and medical technology sectors. I look forward to working closely with both of them as we continue helping customers unlock new insights across genomics, multiomics, and human health.”

Sullivan is in charge of Illumina’s global commercial organization. He has more than 30 years of commercial leadership experience across diagnostics, precision medicine, healthcare, and life sciences, with a proven track record of driving growth, expanding customer adoption, and leading high-performing global teams.

Most recently, Sullivan was chief commercial officer at Caris Life Sciences, where he led the company’s global commercial operations across oncology diagnostics and precision medicine. Before Caris, he held senior commercial leadership roles at Roche Diagnostics, Ortho Clinical Diagnostics, IDEXX Laboratories, and Abbott Diagnostics.

As chief legal officer, Coletti leads Illumina’s global legal, regulatory, and government affairs teams and serves as corporate secretary to the Illumina Board of Directors. Coletti joins the company with extensive legal, regulatory, and governance expertise across the life sciences and medical technology sectors.

Previously, Coletti was chief legal and regulatory officer at Align Technology. Before that, she held senior legal leadership positions at Danaher Corporation and Bayer HealthCare, advising executive leaders and Boards of Directors on a broad range of complex issues, including compliance matters, intellectual property, competition, governance, and public policy. She also serves as a director for Fortis Life Sciences, a solutions provider to life science and diagnostic companies.

Illumina is improving human health by unlocking the power of the genome. It brands itself as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The company’s products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.